Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omics phenotyping in heart failure: the next frontier
Antoni Bayés‐Genís, Peter P. Liu, David E. Lanfear, et al.
European Heart Journal (2020) Vol. 41, Iss. 36, pp. 3477-3484
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Biomarkers for the diagnosis and management of heart failure
Vincenzo Castiglione, Alberto Aimo, Giuseppe Vergaro, et al.
Heart Failure Reviews (2021) Vol. 27, Iss. 2, pp. 625-643
Open Access | Times Cited: 312
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
Wouter C. Meijers, Antoni Bayés‐Genís, Alexandre Mebazaa, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1610-1632
Open Access | Times Cited: 117
Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction
Fanglin Guan, Tong Ni, Weili Zhu, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 113-126
Open Access | Times Cited: 57
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Arantxa González, Mark Richards, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 927-943
Open Access | Times Cited: 51
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
Tariq Ahmad, Nihar R. Desai, Yu Yamamoto, et al.
JAMA Cardiology (2022) Vol. 7, Iss. 9, pp. 905-905
Open Access | Times Cited: 40
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
Bart J van Essen, Jasper Tromp, Jozine M. ter Maaten, et al.
European Journal of Heart Failure (2022) Vol. 25, Iss. 1, pp. 35-42
Open Access | Times Cited: 39
An Integrated Multi-Omics and Artificial Intelligence Framework for Advance Plant Phenotyping in Horticulture
Danuta Cembrowska-Lech, Adrianna Krzemińska, Tymoteusz Miller, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1298-1298
Open Access | Times Cited: 34
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure
Wouter Ouwerkerk, João Pereira, Troy Maasland, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 20, pp. 1921-1931
Open Access | Times Cited: 23
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology
Antoni Bayés‐Genís, Alberto Aimo, Pardeep S. Jhund, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1767-1777
Open Access | Times Cited: 34
Management of cardiac fibrosis is the largest unmet medical need in heart failure
Javier Dı́ez, Rudolf A. de Boer
Cardiovascular Research (2021) Vol. 118, Iss. 2, pp. e20-e22
Open Access | Times Cited: 38
Insulin-like growth factor-binding protein-7 (IGFBP7) links senescence to heart failure
Liyong Zhang, David Smyth, Mohammad Al‐Khalaf, et al.
Nature Cardiovascular Research (2022) Vol. 1, Iss. 12, pp. 1195-1214
Open Access | Times Cited: 25
Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review
Jiliu Pan, Sher May Ng, Stefan Neubauer, et al.
European Heart Journal - Cardiovascular Imaging (2023) Vol. 24, Iss. 10, pp. 1302-1317
Open Access | Times Cited: 15
Circulating Cardiovascular Biomarkers in Cancer Therapeutics‐Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions
Gillian Murtagh, James L. Januzzi, Marielle Scherrer‐Crosbie, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 21
Open Access | Times Cited: 14
Mass Spectrometry Imaging-Based Single-Cell Lipidomics Profiles Metabolic Signatures of Heart Failure
Jie Ren, Haowen Li, Liang Chen, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 13
Treatment of HF in an Era of Multiple Therapies
Ankeet S. Bhatt, William T. Abraham, JoAnn Lindenfeld, et al.
JACC Heart Failure (2020) Vol. 9, Iss. 1, pp. 1-12
Open Access | Times Cited: 33
Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Moritz Hundertmark, Olorunsola F. Agbaje, Ruth L. Coleman, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 4, pp. 2580-2590
Open Access | Times Cited: 31
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
Paolo Morfino, Alberto Aimo, Vincenzo Castiglione, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 8, pp. 256-256
Open Access | Times Cited: 20
The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
Héctor Bueno, Brenda Moura, Patrizio Lancellotti, et al.
European Heart Journal (2020) Vol. 42, Iss. 6, pp. 657-670
Open Access | Times Cited: 31
Plasma amino acid profiling improves predictive accuracy of adverse events in patients with heart failure
Hidemichi Kouzu, Satoshi Katano, Toshiyuki Yano, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 6, pp. 5045-5056
Open Access | Times Cited: 25
Network-based identification of diagnosis-specific trans-omic biomarkers via integration of multiple omics data
Md Mamunur Rashid, Momoko Hamano, Midori Iida, et al.
Biosystems (2024) Vol. 236, pp. 105122-105122
Closed Access | Times Cited: 3
Integrative Proteomic and Metabolomic Elucidation of Cardiomyopathy with in vivo, in vitro Models and Clinical Samples
Yiwei Hu, Yunzeng Zou, Liang Qiao, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3288-3312
Closed Access | Times Cited: 3
Association between the nurse-led program with mental health status, quality of life, and heart failure rehospitalization in chronic heart failure patients
Yuzhu Mo, Mingzi Chu, Wen-Xiong Hu, et al.
Medicine (2021) Vol. 100, Iss. 10, pp. e25052-e25052
Open Access | Times Cited: 22
Circulating metabolic signatures of heart failure in precision cardiology
Huijing Xie, Bowen Zhang, Maodi Xie, et al.
Precision Clinical Medicine (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Heart Failure Incidence Following ST-Elevation Myocardial Infarction
Ricardo Costa, Maria Trêpa, Marta Fontes Oliveira, et al.
The American Journal of Cardiology (2021) Vol. 164, pp. 14-20
Closed Access | Times Cited: 20
Multiomics, Virtual Reality and Artificial Intelligence in Heart Failure
Patrick Gladding, Suzanne Loader, Kevin Smith, et al.
Future Cardiology (2021) Vol. 17, Iss. 8, pp. 1335-1347
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top